Mark Whittaker

5.4k citations

107 papers · 4.3k indexed · 1 hit paper · h-index 34

Impact in

Cancer Research top 2%
- Protease and Inhibitor Mechanisms
Organic Chemistry top 1%
- Click Chemistry and Applications

Papers in ⓘ

Molecular Biology 42
- Chemical Synthesis and Analysis 11
- Receptor Mechanisms and Signaling 10
Organic Chemistry 36

Co-authors: Christopher D. Floyd (7 shared papers)Peter de Nully Brown (6 shared papers)A. J. H. Gearing (4 shared papers)R. Paul Beckett (14 shared papers)Leon Black (5 shared papers)Heather Tye (12 shared papers)Alan H. Drummond (7 shared papers)Osamu Ichihara (7 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (14 papers)Tetrahedron Letters (11 papers)Cancer Research (6 papers)Advances in Cement Research (4 papers)Combinatorial Chemistry & High Throughput Screening (3 papers)
Partner nations: United Kingdom Germany United States

In The Last Decade

Mark Whittaker

107 papers receiving 4.1k citations

Hit Papers

align trajectories log scale

Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors 1999 · 851 citations

Peers

Countries citing papers authored by Mark Whittaker

Since Specialization

Citations

This map shows the geographic impact of Mark Whittaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Whittaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Whittaker more than expected).

Fields of papers citing papers by Mark Whittaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Whittaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Whittaker. The network helps show where Mark Whittaker may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Whittaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Whittaker Line = papers co-authored together Mark Whittaker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors Chemical Reviews ·Mark Whittaker, Christopher D. Floyd, Peter de Nully Brown, A. J. H. Gearing Hit paper breakdown →	1999	851
2	Recent advances in matrix metalloproteinase inhibitor research Drug Discovery Today ·R. Paul Beckett, A DAVIDSON, Alan H. Drummond, PHIL HUXLEY, Mark Whittaker	1996	232
3	Antibiotic Activity and Characterization of BB-3497, a Novel Peptide Deformylase Inhibitor Antimicrobial Agents and Chemotherapy ·John M. Clements, R. Paul Beckett, Anthony Brown, Graham Catlin, Mario Lobell, Shilpa Palan, Wayne Thomas, Mark Whittaker, Stephen Wood, Sameeh M. Salama, Patrick J. Baker, H. Fiona Rodgers, V.V. Barynin, David W. Rice, Michael Hunter	2001	188
4	Preclinical and Clinical Studies of MMP Inhibitors in Cancer Annals of the New York Academy of Sciences ·Alan H. Drummond, Paul Beckett, Peter de Nully Brown, Elisabeth A. Bone, Alan H. Davidson, W A Galloway, Andy J.H. Gearing, PHIL HUXLEY, DAVID LABER, Matthew McCourt, Mark Whittaker, L. Michael Wood, Annette Wright	1999	181
5	The role of the alumina content of slag, plus the presence of additional sulfate on the hydration and microstructure of Portland cement-slag blends Cement and Concrete Research ·Mark Whittaker, Maciej Zając, Mohsen Ben Haha, Frank Bullerjahn, Leon Black	2014	151
6	Efficient Solvent-Free Selective Monoalkylation of Arylacetonitriles with Mono-, Bis-, and Tris-primary Alcohols Catalyzed by a CpIr Complex The Journal of Organic Chemistry* ·Christian Löfberg, Ronald Grigg, Mark Whittaker, Ann Keep, Andrew Derrick	2006	121
7	Matrix metalloproteinase inhibitors 1998 Expert Opinion on Therapeutic Patents ·R. Paul Beckett, Mark Whittaker	1998	116
8	Current knowledge of external sulfate attack Advances in Cement Research ·Mark Whittaker, Leon Black	2015	111
9	Prediction of cyclin-dependent kinase 2 inhibitor potency using the fragment molecular orbital method Journal of Cheminformatics ·Michael P. Mazanetz, Osamu Ichihara, Richard Law, Mark Whittaker	2011	96
10	A method for the synthesis of hydroxamic acids on solid phase Tetrahedron Letters ·Christopher D. Floyd, H Lewis, Sanjay R. Patel, Mark Whittaker	1996	88
11	Microwave-assisted multi-component synthesis of fused 3-aminoimidazoles Tetrahedron Letters ·Sarah M. Ireland, Heather Tye, Mark Whittaker	2003	87
12	Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ Bioorganic & Medicinal Chemistry Letters ·Lloyd G. Czaplewski, Ian Collins, Edward A. Boyd, David R. Brown, Stephen P. East, Mihaly Gardiner, Rowena Fletcher, David J. Haydon, Vincent Henstock, P. L. Ingram, Clare A. Jones, Caterina Noula, Leanne Kennison, Chris Rockley, Valérie Rose, Helena Thomaides‐Brears, Rebecca Ure, Mark Whittaker, Neil R. Stokes	2008	79
13	Compound Design by Fragment‐Linking Molecular Informatics ·Osamu Ichihara, John J. Barker, Richard Law, Mark Whittaker	2011	68
14	Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity Journal of Crohn s and Colitis ·Daniel Pearl, Mojgan Masoodi, Michael Eiden, Janine Brümmer, Darren R. Gullick, Tricia M. McKeever, Mark Whittaker, Harriet Nitch‐Smith, J F Brown, Janis K. Shute, Graham A. Mills, Philip C. Calder, Timothy M Trebble	2013	68
15	Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist British journal of surgery ·Laura Formela, Landon Wood, Mark Whittaker, A N Kingsnorth	1994	67
16	Update on the Development of Antagonists of Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2). From Lead Optimization to Clinical Proof-of-Concept in Asthma and Allergic Rhinitis Journal of Medicinal Chemistry ·Roy Pettipher, Mark Whittaker	2012	62
17	Use of a Design of Experiments approach for the optimisation of a microwave assisted Ugi reaction Organic & Biomolecular Chemistry ·Heather Tye, Mark Whittaker	2004	58
18	Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors. (Chem. Rev. 1999, 99, 2735−2776. Published on the Web September 8, 1999). Chemical Reviews ·Mark Whittaker, Christopher D. Floyd, Peter de Nully Brown, A. J. H. Gearing	2001	58
19	The impact of alumina availability on sulfate resistance of slag composite cements Construction and Building Materials ·Mark Whittaker, Maciej Zając, Mohsen Ben Haha, Leon Black	2016	55
20	An in Silico Method for Predicting Ames Activities of Primary Aromatic Amines by Calculating the Stabilities of Nitrenium Ions Journal of Chemical Information and Modeling ·Jörg Bentzien, Eugene R. Hickey, Raymond A. Kemper, Mark L. Brewer, Jane Dannow Dyekjær, Stephen P. East, Mark Whittaker	2010	53

About Mark Whittaker

Mark Whittaker is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Cancer Research and Inorganic Chemistry, having authored 107 papers that have together received 4.3k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (16 papers), Protease and Inhibitor Mechanisms (14 papers), Chemical Synthesis and Analysis (11 papers), Receptor Mechanisms and Signaling (10 papers), Asymmetric Hydrogenation and Catalysis (10 papers), Computational Drug Discovery Methods (10 papers), Metal-Catalyzed Oxygenation Mechanisms (9 papers) and Concrete and Cement Materials Research (9 papers). The work is most often cited by research in Cancer Research (945 citations), Organic Chemistry (1.4k citations), Oncology (1.2k citations), Molecular Biology (1.9k citations) and Computational Theory and Mathematics (384 citations). Mark Whittaker has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Christopher D. Floyd, Peter de Nully Brown, A. J. H. Gearing, R. Paul Beckett, Leon Black, Heather Tye, Alan H. Drummond, Osamu Ichihara, Thomas Hesterkamp and Richard Law. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Cancer Research, Advances in Cement Research and Combinatorial Chemistry & High Throughput Screening.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact